Clinical Trial

Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
Deep surgical site infection (DSSI) is one of the most challenging complications for spinal surgeons and can lead to a poor clinical outcome. This ambispective study was designed to examine the effect of vancomycin powder mixed with autogenous bone graft and bone substitute on preventing deep surgical site infection (DSSI) in degenerative lumbar fusion surgeries as well as any interference with bony fusion.
Trial Details
NCT Number NCT03883022
Lead Sponsor Taipei Veterans General Hospital, Taiwan
Conditions Spinal Fusion, Spinal Stenosis, Spondylolisthesis
Enrollment 400 participants
Start Date 2018-09-03
Primary Completion 2027-09-12 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2019-03-20